Home Companies Novartis

Novartis

Latest

Gene Therapy

Gene Therapy Briefs: Cure Rare Disease CEO’s Brother Died in Clinical Trial

3D illustration XY-chromosomes as a concept for human biology medical symbol gene therapy or microbiology genetics research

Gene Therapy

Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma

Financing

StockWatch: Layoffs Fail to Lift Novartis

Genome Editing

Beyond CRISPR: Precision Bio Lands Up-to-$1.5B Editing Deal with Novartis

Novartis

Novartis Eliminating 8,000 Jobs in Global Restructuring

Precision Medicine

It Takes Two: Tango Therapeutics Leverages Synthetic Lethality in Precision Cancer...

illustration Geometric abstract background with connected line and dots,Futuristic digital background for Science and technology

Novartis

Novartis Jumpstarts Presence in Protein Degradation with Up-to-$1.3B Dunad Collaboration

Illustration of human blood cells

Novartis

Bleeding Edge: Anthos Pursues a Monthly Anticoagulant

Novartis

Mountain Climbing: Dyno Fights AAV Vector Immune Response with $100M

Burkitt's lymphoma cells, illustration

Novartis

Novartis, Artios Pharma Target Cancer in Up-to-$1.3B DDR Collaboration

Novartis

Sangamo CEO Ponders Pipeline, Reflects on Phase III ‘Proud Moment’

Novartis

A New Vision for Gene Therapy

Novartis

Novartis Taps Sangamo Zinc Finger Tech for Gene Regulation Therapies

Novartis

Dyno Inks Up to $2B+ in Gene Therapy Partnerships with Novartis,...

Novartis

Novartis Plans Phase III Trial of Hydroxychloroquine for COVID-19

12 Page 1 of 2